Clin2
NCT06027554Possibly a fitRecruiting

MitoQ for frailty, walking, memory, and blood flow in older adults

FrailtyMild Cognitive ImpairmentAging

Part of Mental health clinical trials.

This trial tests whether a supplement called MitoQ can improve blood vessel health, walking speed, and thinking skills in older adults who are frail or have mild memory problems. It aims to see if MitoQ helps maintain independence and quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
65 years to 80 years
Study type
Interventional

Who can take part

  • You are between 65 and 80 years old
  • You walk slowly (less than 0.4 meters per second on a 4-meter walk) or have mild memory or thinking problems
  • You are not taking any medications for blood pressure, blood flow, or metabolism (like diabetes or cholesterol drugs)
  • You have not had a recent infection, vaccination, or hospitalization in the past few weeks to months
  • You do not have a bleeding disorder, are not on blood thinners, and have not had a recent fall
  • You are not taking immune-altering medicines (like high-dose steroids) or have a severe autoimmune disease

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07406243Not yet recruiting
Antioxidant supplement for brain artery health in postmenopausal women

This trial tests whether an oral antioxidant therapy targeting mitochondria can improve the health of brain arteries in postmenopausal women. It may help protect against blood vessel problems that increase with age and after menopause.

Fort Collins, Colorado
NCT07772336Not yet recruiting
Coenzyme Q10 for resilience in older adults

This study tests whether a daily supplement of Coenzyme Q10 (a natural substance that helps cells produce energy) can improve physical strength and resilience in older adults who show early signs of frailty. It aims to help people stay independent and active as they age.

NCT06208527Recruiting· Phase 2
Nicotinamide Riboside for Frailty in Older Adults

This trial tests whether a daily supplement called nicotinamide riboside can help older adults who feel weak or frail to get stronger and more energetic. It lasts for several months and involves simple tests like a walking test and memory checks.

Bergen, Vestland
NCT07144527Recruiting
NMN supplement for exercise in healthy older adults

This trial tests whether a supplement called nicotinamide mononucleotide (NMN) can help healthy adults aged 60 to 80 improve their exercise tolerance. You'll take the supplement and do supervised cycling sessions to see if it boosts your stamina.

Beverly Hills, California
NCT06470061Not yet recruiting· Phase 2
RQC pill to prevent Alzheimer's and eye amyloid buildup

This trial tests an oral medication called RQC to see if it can prevent Alzheimer's disease and related protein buildup in the eye. It is for people aged 50-90 who are generally healthy and do not have memory or thinking problems.

Chicago, Illinois
NCT06191965Recruiting· Phase 2/Phase 3
MitoQ supplement for early psychosis

This study tests whether a supplement called MitoQ can help people with early-stage psychosis by improving how their cells produce energy. If you are younger and have been treated for psychosis for less than 5 years, this trial may be an option for you.

New Haven, Connecticut

Hear when a new Frailty trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.